Gene · 4171
Papers3,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of robust antiviral assays using relevant apical-out human airway organoids. | bioRxiv | 2024 | 38260306 | PubTator, text mining | PubMed |
| Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice. | Medicina (Kaunas) | 2024 | 38256428 | PubTator, text mining | PubMed |
| Temporal Quantitative Proteomic and Phosphoproteomic Profiling of SH-SY5Y and IMR-32 Neuroblastoma Cells during All-Trans-Retinoic Acid-Induced Neuronal Differentiation. | Int J Mol Sci | 2024 | 38256121 | PubTator, text mining | PubMed |
| The histone chaperone SPT2 regulates chromatin structure and function in Metazoa. | Nat Struct Mol Biol | 2024 | 38238586 | PubTator, text mining | PubMed |
| The multifaceted role of Fragile X-Related Protein 1 (FXR1) in cellular processes: an updated review on cancer and clinical applications. | Cell Death Dis | 2024 | 38238286 | PubTator, text mining | PubMed |
| Heterogeneous Expression Patterns of the Minichromosome Maintenance Complex Members in Retinoblastoma Unveil Its Clinical Significance. | Invest Ophthalmol Vis Sci | 2024 | 38231525 | PubTator, text mining | PubMed |
| Role of Serine arginine protein kinase 1 and Minichromosome maintenance protein 2 in predicting epithelial ovarian cancer response to treatment and prognosis. | Indian J Cancer | 2024 | 38216547 | PubTator, text mining | PubMed |
| Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. | J Enzyme Inhib Med Chem | 2024 | 38205514 | PubTator, text mining | PubMed |
| HCC-Related lncRNAs: Roles and Mechanisms. | Int J Mol Sci | 2024 | 38203767 | PubTator, text mining | PubMed |
| The role of cryptic ancestral symmetry in histone folding mechanisms across Eukarya and Archaea. | PLoS Comput Biol | 2024 | 38181064 | PubTator, text mining | PubMed |
| Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. | Nat Commun | 2024 | 38167338 | PubTator, text mining | PubMed |
| Pharmaceutical characterization and exploration of Arkeshwara rasa in MDA-MB-231 cells. | J Ayurveda Integr Med | 2024 | 38160612 | PubTator, text mining | PubMed |
| EFNB1 levels determine distinct drug response patterns guiding precision therapy for B-cell neoplasms. | iScience | 2024 | 38155773 | PubTator, text mining | PubMed |
| Rapid conversion of porcine pluripotent stem cells into macrophages with chemically defined conditions. | J Biol Chem | 2024 | 38097188 | PubTator, text mining | PubMed |
| Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer. | Transl Oncol | 2024 | 37992591 | PubTator, text mining | PubMed |
| The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy. | Genes Dis | 2024 | 37692484 | PubTator, text mining | PubMed |
| PPM1D activity promotes the replication stress caused by cyclin E1 overexpression. | Mol Oncol | 2024 | 37067201 | PubTator, text mining | PubMed |
| Expression analysis of cyclin D, Ki-67, MCM3 and MCM2 in oral squamous cell carcinoma. | Bioinformation | 2023 | 38415027 | PubTator, text mining | PubMed |
| Minichromosome maintenance protein 5 - a promising prognostic marker of oral epithelial dysplasias and oral squamous cell carcinomas. | J Oral Maxillofac Pathol | 2023 | 38304521 | PubTator, text mining | PubMed |
| Role of proliferative markers in assessing recurrences in surgical margins of oral squamous cell carcinoma: A systematic review. | J Oral Maxillofac Pathol | 2023 | 38304496 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4171/papers?page=9